Last reviewed · How we verify

NCT03714360

The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery.

Completed Phase 4 Last updated 31 January 2025
What this trial tests

Phase 4 trial testing Tranexamic Acid in Pharmacological Action in 250 participants. Completed in 16 August 2016.

Timeline
19 October 2015
Primary endpoint
16 August 2016
16 August 2016

Quick facts

Lead sponsorMikkel Østerheden Andersen
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment250
Start date19 October 2015
Primary completion16 August 2016
Estimated completion16 August 2016
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Mikkel Østerheden Andersen

Who can join

Eligibility, any sex, with Pharmacological Action. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this randomized double blind placebo controlled study of tranexamic acid during minor spinal surgery, mean postoperative blood loss in the patients who received TXA was statistically significantly lower compared to placebo.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Double-blind, randomized controlled trial of tranexamic acid in minor lumbar spine surgery: no effect on operative time, intraoperative blood loss, or complications.
    Elmose S, Andersen MØ, Andresen EB, Carreon LY. · · 2019 · cited 18× · PMID 30978683 · DOI 10.3171/2019.1.spine1814

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

Other recruiting trials for Pharmacological Action

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03714360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing